May 08, 2026

Cardiovascular Effects and Risk Factors Identified With BRAF and MEK Inhibition in Melanoma

A cohort study showed that patients with melanoma who received BRAF or MEK inhibitor therapy commonly experienced hypertension and mild cardiac dysfunction, supporting baseline cardiotoxicity risk str...

The ASCO Post

May 04, 2026

CLL Linked to Increased Skin Cancer Risk and Mortality

In a nationwide population–based cohort study reported in JAMA Dermatology, Blomberg Drejøe et al evaluated the long-term risk of skin cancer and related outcomes among patients with chronic lymphocyt...

The ASCO Post

May 04, 2026

AI Shows Dermatologist-Level Accuracy in Melanoma Diagnosis but Needs Validation

In a systematic review and meta-analysis published in JAMA Dermatology, Laiouar-Pedari et al evaluated the real-world diagnostic performance of artificial intelligence (AI)–assisted dermoscopy for mel...

The ASCO Post

May 01, 2026

Melanoma: Gut Microbiome May Help Predict Recurrence After Immunotherapy

Gut bacterial markers may be able to predict recurrence in patients with high-risk melanoma receiving adjuvant immune checkpoint inhibition, according to study findings published in Cell. 

The ASCO Post

April 17, 2026

Melanoma: Can AI Enable Diagnosis Prediction?

Assessment of machine-learning models tested on Swedish registry data enabled more accurate melanoma diagnosis prediction, with added health-care code, age, sex, and medication information for improve...

The ASCO Post

April 17, 2026

Melanoma: Can AI Enable Diagnosis Prediction?

Assessment of machine-learning models tested on Swedish registry data enabled more accurate melanoma diagnosis prediction, with added health-care code, age, sex, and medication information for improve...

The ASCO Post

April 17, 2026

Melanoma: Can AI Enable Diagnosis Prediction?

Assessment of machine-learning models tested on Swedish registry data enabled more accurate melanoma diagnosis prediction, with added health-care code, age, sex, and medication information for improve...

The ASCO Post

April 13, 2026

James P. Allison, PhD, Honored With the 2026 AACR Award for Lifetime Achievement in Cancer Research

Dr. Allison is being recognized for his lifelong scientific achievements and transformative contributions to cancer research and patient care. Most notably, he is being celebrated for his identificati...

The ASCO Post

April 13, 2026

Antoni Ribas, MD, PhD, Honored With the 2026 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research

The recipient of the 2026 award is being recognized for his exceptional leadership and extraordinary achievements in cancer research, including pioneering contributions to melanoma biology and cancer ...

The ASCO Post

April 13, 2026

Antoni Ribas, MD, PhD, Honored With the 2026 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research

The recipient of the 2026 award is being recognized for his exceptional leadership and extraordinary achievements in cancer research, including pioneering contributions to melanoma biology and cancer ...

The ASCO Post